PSDV - EyePoint Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
1.22
+0.15 (+14.02%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close1.07
Open1.33
Bid0.00 x 0
Ask0.00 x 0
Day's Range1.16 - 1.34
52 Week Range0.93 - 2.45
Volume1,183,129
Avg. Volume397,026
Market Cap55.214M
Beta-1.28
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of PSDV earnings conference call or presentation 7-Feb-18 9:30pm GMT

    Q2 2018 pSivida Corp Earnings Call

  • Associated Press2 months ago

    PSivida reports 2Q loss

    On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of 13 cents. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks ...

  • Capital Cube4 months ago

    ETFs with exposure to pSivida Corp. : December 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube5 months ago

    ETFs with exposure to pSivida Corp. : November 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • pSivida Corp. :PSDV-US: Earnings Analysis: Q1, 2018 By the Numbers : November 29, 2017
    Capital Cube5 months ago

    pSivida Corp. :PSDV-US: Earnings Analysis: Q1, 2018 By the Numbers : November 29, 2017

    Categories: Yahoo FinanceGet free summary analysis pSivida Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of pSivida Corp. – Nektar Therapeutics, Regeneron Pharmaceuticals, Inc., XOMA Corporation, Alimera Sciences, Inc., Valeant Pharmaceuticals International Inc, Merck & Co., Inc., Heron Therapeutics Inc, Abbott Laboratories and Pfizer Inc. ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of PSDV earnings conference call or presentation 7-Nov-17 1:30pm GMT

    Q1 2018 pSivida Corp Earnings Call

  • Associated Press6 months ago

    PSivida reports 1Q loss

    On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of 15 cents. The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...

  • Capital Cube7 months ago

    ETFs with exposure to pSivida Corp. : September 18, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Thomson Reuters StreetEvents7 months ago

    Edited Transcript of PSDV earnings conference call or presentation 11-Sep-17 8:30pm GMT

    Q4 2017 pSivida Corp Earnings Call

  • Is pSivida Corp (PSDV) Undervalued?
    Simply Wall St.7 months ago

    Is pSivida Corp (PSDV) Undervalued?

    pSivida Corp (NASDAQ:PSDV), a pharmaceuticals, biotechnology and life sciences company based in United States, Check out our latest analysis for pSivida Is PSDV still cheap? Good news, investors! PSDV isRead More...

  • Thomson Reuters StreetEvents10 months ago

    Edited Transcript of PSDV earnings conference call or presentation 4-May-17 8:30pm GMT

    Q3 2017 pSivida Corp Earnings Call

  • Associated Presslast year

    PSivida reports 3Q loss

    The Watertown, Massachusetts-based company said it had a loss of 15 cents per share. The drug delivery technology company posted revenue of $590,000 in the period. In the final minutes of trading on Thursday, ...